Terlipressin improves renal outcomes in hepatorenal syndrome: CONFIRM Study Dr Kartikeya Kohli10 March 2021 10:15 AM ISTHepatorenal syndrome (HRS) is a fatal complication of advanced cirrhosis with ascites and liver failure, with nearly 50% of patients dying within...
Interleukin (IL)-1 inhibitor rilonacept resolves and prevents recurrent pericarditis MD Bureau7 Jan 2021 4:00 AM ISTIn patients with recurrent pericarditis, treatment with rilonacept, an engineered fusion protein that acts as an IL-1 trap, leads to a rapid...
Once-Weekly Insulin as effective as once-daily insulin in type 2 Diabetes: NEJM Dr. Nandita Mohan26 Nov 2020 4:00 AM ISTResearchers have found that Once-weekly treatment with insulin icodec had blood sugar lowering efficacy and a safety profile similar to those of...
Polypill along with aspirin cuts heart attacks and strokes by up to 40%: TIPS-3 Study Hina Zahid19 Nov 2020 3:00 PM ISTIndia - Heart attacks, strokes and other cardiovascular incidents can be cut by 20 to 40 per cent through use of a polypill which combines three...
NEJM:Monoclonal antibody treatment lowered viral load in COVID-19, indicates clinical trial Hina Zahid1 Nov 2020 2:45 PM ISTCOVID-19 convalescent plasma–derived virus-neutralizing monoclonal antibody treatment (LY-CoV555) reduced viral loads, lowered the severity of...
Empagliflozin may reduce hospitalization and death risk in heart failure: Study Dr Satabdi Saha26 Oct 2020 8:00 AM ISTAccording to a recent research, patients receiving empagliflozin therapy for heart failure, showed a lower risk of cardiovascular death or...
Dapagliflozin reduces Renal Risk in CKD, irrespective of Diabetes Status: NEJM Dr Satabdi Saha25 Sept 2020 8:58 PM ISTThe sodium-glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin reduces the risk for kidney disease progression and death in patients with chronic...
NEJM study confirms cardiac safety of Ertugliflozin in diabetes Dr Satabdi Saha25 Sept 2020 3:15 PM ISTAmong patients with type 2 diabetes and atherosclerotic cardiovascular disease, ertugliflozin was non-inferior to placebo concerning major adverse...
Even lower doses of zinc effective in diarrhea in children, claims NEJM study Dr Satabdi Saha25 Sept 2020 3:15 PM ISTLower doses of zinc had similar efficacy for the treatment of diarrhea in children and were associated with less vomiting, than the standard 20-mg...
Belimumab addition to standard therapy improves results in lupus Nephritis: NEJM Dr Satabdi Saha21 Sept 2020 10:00 AM ISTLupus nephritis, which occurs in 25 to 60% of patients with systemic lupus erythematosus (SLE), is the most common severe manifestation of SLE and a...
Duodenal Microbiota and Enteropathy linked to Stunted growth in Children: NEJM Dr Satabdi Saha9 Sept 2020 6:00 PM ISTAccording to the reports of a study, recently published in The New England Journal Of Medicine, a causal relationship has emerged between growth...
Saliva swab as good as nasal swab for diagnosing COVID-19 infection, finds NEJM study Dr Satabdi Saha7 Sept 2020 4:01 PM ISTSaliva swabs have shown equal efficacy to nasopharyngeal swabs in tests to confirm infection with SARS-CoV-2, suggests a recent study.The findings of...
